Pfizer’s BEQVEZ (fidanacogene elaparvovec-dzkt) Receives US FDA Approval for Adults with Hemophilia B
Shots: US FDA granted approval to Pfizer’s BEQVEZ, based on
US FDA Grants Fast Track Designation to Compass Therapeutics’ CTX-009 with Paclitaxel for Previously Treated Metastatic or Locally...
Shots: Compass received US FDA’s FTD for CTX-009 with paclitaxel to treat me...
Medivir’s MIV-711 Receives FDA ODD and RPDD for Legg-Calvé-Perthes Disease
Shots: US FDA granted ODD and RPDD to Medivir’s MIV-711 for treatment of Leg...
Blue Arbor’s RESTORE Neuromuscular Interface System Receives FDA Breakthrough Device Designation & TAP Enrolment
Shots: US FDA granted BTD designation to Blue Arbor’s RESTORE Neuromuscular...
Ascendis Pharma Receives MHRA Approval for YORVIPATH (Palopegteriparatide) Against Chronic Hypoparathyroidism in Great Britain
Shots: The MHRA has granted marketing authorization to Ascendis’ Yorvipath (...
CSL Vifor and Travere Therapeutics’ FILSPARI (sparsentan) Received European Commission Approval Against IgA Nephropathy
Shots: FILSPARI received conditional marketing authorization (CMA) from European C...
